p53 Modulates the Exonuclease Activity of Werner Syndrome Protein
Open Access
- 1 September 2001
- journal article
- Published by Elsevier BV
- Vol. 276 (37), 35093-35102
- https://doi.org/10.1074/jbc.m103332200
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Werner Syndrome ProteinPublished by Elsevier BV ,1998
- The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.Journal of Bone and Joint Surgery, 1996
- Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.Published by Cold Spring Harbor Laboratory ,1994
- p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genesNature, 1994
- A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.Journal of Bone and Joint Surgery, 1993
- The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.Genes & Development, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- p53, guardian of the genomeNature, 1992
- Effects of the cellular p53 protein on Simian‐virus‐40‐T‐antigen‐catalyzed DNA unwinding in vitroJBIC Journal of Biological Inorganic Chemistry, 1989
- A Review of its Symptomatology, Natural History, Pathologic Features, Genetics And Relationship to the Natural Aging ProcessMedicine, 1966